The Latest Breaking News from Cancer

On Wednesday, Amgen Inc. (NASDAQ:AMGN) and its partner Zai Lab (NASDAQ:ZLAB) said the final analysis of the Phase 3 FORTITUDE-101 trial evaluating bemarituzumab in combination with chemotherapy (mFOLFOX6) in first-line gastric cancer has been completed.

The U.S. Food and Drug Administration (FDA) on Thursday granted Breakthrough Therapy designation to Eli Lilly and Co.’s (NYSE:LLY) olomorasib, in combination with Merck Co. Inc.’s (NYSE:MRK) anti-PD-1 therapy Keytruda (pembrolizumab), for the first-line treatment of unresectable advanced or metastatic non-small cell lung cancer (NSCLC) with a KRAS G12C mutation…

Experts called the gain for myeloma patients ‘impressive’ but said continued research is needed to continue progress.

The Carrollton, Ohio, man stopped at a gas station in Malvern on his way home from taking his wife to cancer treatment appointments

Artelo Biosciences, Inc. (NASDAQ:ARTL) on Wednesday released interim results from its Phase 2 Cancer Appetite Recovery Study (CAReS) trial with ART27.13, the company’s peripherally acting cannabinoid receptor agonist for cancer anorexia-cachexia syndrome (CACS).

"William stepping up is important because one day that will be his role."

King charles discussed his health as he opened a new hospital in the Midlands

Raveling's family said Tuesday in a statement that he had ‘faced cancer with courage and grace’

Chef shows off surgical stitches, jokes it's not a facelift.